Toxicity After Cytoreduction With Busulfan Alone in 37 Patients Autografted for CML
| . | Cardiac . | Bladder . | Renal . | Respiratory . | Hepatic . | CNS . | Stomatitis . | Gastrointestinal . |
|---|---|---|---|---|---|---|---|---|
| Grade III or less | 0 | 0 | 1 (3%) | 0 | 0 | 0 | 0 | 0 |
| Grade II or less | 0 | 0 | 2 (5%) | 0 | 1 (3%) | 0 | 28 (76%) | 0 |
| Grade I only | 0 | 0 | 3 (8%) | 0 | 2 (5%) | 0 | 9 (24%) | 5 (14%) |
| Total with any degree of toxicity | 0 | 0 | 6 (16%) | 0 | 3 (8%) | 0 | 37 (100%) | 5 (14%) |
| . | Cardiac . | Bladder . | Renal . | Respiratory . | Hepatic . | CNS . | Stomatitis . | Gastrointestinal . |
|---|---|---|---|---|---|---|---|---|
| Grade III or less | 0 | 0 | 1 (3%) | 0 | 0 | 0 | 0 | 0 |
| Grade II or less | 0 | 0 | 2 (5%) | 0 | 1 (3%) | 0 | 28 (76%) | 0 |
| Grade I only | 0 | 0 | 3 (8%) | 0 | 2 (5%) | 0 | 9 (24%) | 5 (14%) |
| Total with any degree of toxicity | 0 | 0 | 6 (16%) | 0 | 3 (8%) | 0 | 37 (100%) | 5 (14%) |